Superworth

CTS revenue CTS

Sales by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
$564.3M
Latest quarter, Q2 FY26
$144.8M
+7% on a year earlier
Fiscal year 2025
$541.3M
+5% on the year before

CTS' revenue was $564.3M over the twelve months to Jun 30, 2026, up 9% on a year earlier.

In its latest quarter, Q2 FY26, it was $144.8M, up 7% on the same quarter a year before.

Over the five fiscal years to FY2025 it grew 5% a year on average.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2025$541.3M+5%
FY2024$514.8M−6%
FY2023$550.4M−6%
FY2022$586.9M+14%
FY2021$512.9M+21%
FY2020$424.1M−10%
FY2019$469M−0%
FY2018$470.5M+11%
FY2017$423M+7%
FY2016$396.7M+4%
FY2015$382.3M−5%
FY2014$404M−1%
FY2013$409.5M+34%
FY2012$304.5M−48%
FY2011$588.5Mn/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q2 FY26$144.8M+7%$564.3M
Q1 FY26$139.2M+11%$554.8M
Q4 FY25$137.3M+9%$541.3M
Q3 FY25$143M+8%$530.5M
Q2 FY25$135.3M+4%$519.9M
Q1 FY25$125.8M+0%$514.8M
Q4 FY24$126.5M+1%$514.8M
Q3 FY24$132.4M−2%$513M
Q2 FY24$130.2M−10%$515.2M
Q1 FY24$125.8M−14%$530.2M
Q4 FY23$124.7M−12%$550.4M
Q3 FY23$134.6M−11%$568M

Against its peers

Companies in Hardware, Equipment & Parts nearest CTS' size, closest first, today.

CompanyRevenue, 12 monthsGrowth
CTSCTS$564.3M+9% a year
ALNTAllient$574.8M+11% a year
BHEBenchmark Electronics$2.8B+9% a year
VREXVarex Imaging$865M+5% a year
TRNSTranscat$348.4M+21% a year
FEIMFrequency Electronics$72.9M+6% a year
MLABMesa Laboratories$249.7M+3% a year
VPGVishay Precision$328.6M+11% a year
ITRIItron$2.3B−6% a year
KEKimball Electronics$1.4B−4% a year
OLEDUniversal Display$606.9M−8% a year
Peer median$590.8M

Where CTS ranks

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on CTS

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.